Dexamfetamine, a regulated substance, is administered in Australia primarily for the control of Attention-Deficit/Hyperactivity Disorder (ADHD) and, less often, narcolepsy. Its use is strictly regulated under the Therapeutic Goods Act and requires a recent prescription from an Australian register